ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2021

Jun 10, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2021-05-25

Reporting Person: Ma Jiong (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$13.01	2031-06-02	Common Stock (35000)		Direct

Footnotes

F1: Dr. Ma holds options to purchase thirty-five thousand (35,000) shares of common stock of the Company at $13.01. The options will vest annually over a three-year period commencing on June 2, 2021, exercisable as follows: 11,666 on June 2, 2022, 11,667 on June 2, 2023, and 11,667 on June 2, 2024.